ATP-依赖的RNA解旋酶32抗体
3110079L04Rik; AA408140; Ddx32; DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 32; DEAD/H box 32; DEAD/H helicase like protein 1; DEAH (Asp-Glu-Ala-His) box polypeptide 32; DEAH box protein 32;
叉头蛋白D1抗体
Brain Factor 2; FKH L8; FKHL 8; FKHL8; Forkhead (Drosophila) like 8; Forkhead box D1; Forkhead box protein D1; Forkhead drosophila homolog like 8; Forkhead like 8; Forkhead related activator 4; Forkhe
PDZ结构域PDZK3蛋白抗体
IKEPP; Intestinal and kidney enriched PDZ protein; Intestinal and kidney-enriched PDZ protein; Na(+)/H(+) exchange regulatory cofactor NHE-RF4; Na/Pi cotransporter C terminal associated protein 2;
Rho家族GTP酶2抗体
ARHN; Rho 7; Rho family GTPase 2; Rho N; Rho related GTP-binding protein RhoN; Rho-related GTP-binding protein Rho7; Rho-related GTP-binding protein RhoN; Rho7; RhoN; Rnd 2; Rnd2; RND2_HUMAN.
脂肪瘤相关蛋白抗体
DKFZp779O0231; FLJ30652; FLJ41512; LIM domain containing preferred translocation partner in lipoma; LIM domain-containing preferred translocation partner in lipoma; LIM protein; Lipoma preferred
包含氧化还原酶的WW域抗体
D16S432E; FOR; FOR II protein; FRA16D; Fragile 16D oxido reductase; fragile site FRA16D oxidoreductase; HHCMA 56; HHCMA56; PRO0128; putative oxidoreductase; WOX 1; WOX1; WW domain containing oxidoredu
Anti-BID Polyclonal Antibody
Anti-BID Polyclonal Antibody 应用 WB 稀释比例 WB 1:500-2000. 交叉反应 Human
磷酸化抑癌蛋白EZH2抗体
KMT6/EZH2(phospho T487); KMT6/EZH2(phospho Thr487); p-KMT6/EZH2(phospho T487); p-KMT6/EZH2(Thr487); KMT6 / EZH2 (phospho Thr487); p-KMT6/EZH2(T487); Enhancer of zeste homolog 2; Enx1h; MGC9169; Enhanc